Tracking eye cancer patients for 5 years after experimental treatment
NCT ID NCT07338968
Summary
This study follows 100 people for about 5 years after they completed a previous trial testing bel-sar for early eye cancer. Researchers will track long-term safety, treatment effectiveness, and quality of life without giving any new treatments. The goal is to understand how well the treatment works over time and identify any long-term benefits or risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.